Covetrus reports Q1 uptick in sales, shrinking loss

Portland-based animal-health company Covetrus Inc. (Nasdaq: CVET) on Thursday reported financial results for the year’s first quarter, showing an uptick in revenue and a net loss that shrank from the same period’s results last year.

Net sales for the three months ended March 31, 2022, totaled $1.15 billion, an increase of 4% over the amount during Q1 2021. The company reported a loss of $2 million, or 2 cents a share, down from $16 million, or 11 cents a share, in the year-ago period. Read more

Related Posts

Business Leaders: Deborah Bronk steers Bigelow Lab expansion to boost reach, programming

Deborah Bronk is president, CEO and a senior research scientist at Bigelow Laboratory for Ocean Sciences in East Boothbay, which will...

24 March 2025

UNE retains R2 Research status, reinforcing leadership in scientific advancement

The University of New England has retained its status as one of the country’s leading research universities with the recent release...

23 March 2025

Maine college students investigate health effects of forever chemicals

Two dozen Maine college students are investigating the public health effects of forever chemicals by using zebrafish as human stand-ins and...

21 March 2025